Mylan’s $7.2 billion purchase of Meda has strategic value, even if Mylan’s share price fell sharply after the deal was announced.
MarketWatch.com - Top Stories, MarketWatch
Fri, 02/12/2016 - 5:44am
Mylan’s $7.2 billion purchase of Meda has strategic value, even if Mylan’s share price fell sharply after the deal was announced.